171 related articles for article (PubMed ID: 6633999)
21. Measurement of CA-125 in trophoblastic disease.
Kohorn EI
Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
[TBL] [Abstract][Full Text] [Related]
22. Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease.
Gaffield ME; Kapp N; Curtis KM
Contraception; 2009 Oct; 80(4):363-71. PubMed ID: 19751859
[TBL] [Abstract][Full Text] [Related]
23. Elevated titers of the beta subunit of human chorionic gonadotropin in oophorectomized women being treated for trophoblastic disease.
Hatch KD; Shingleton HM; Younger B; Boots LR
Am J Obstet Gynecol; 1980 May; 137(1):122-6. PubMed ID: 7369275
[TBL] [Abstract][Full Text] [Related]
24. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
Kohorn EI
Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
[TBL] [Abstract][Full Text] [Related]
25. Management of postmolar gestational trophoblastic disease with methotrexate and folinic acid: 15 years of experience.
Sekharan PK; Sreedevi NS; Radhadevi VP; Beegam R; Raghavan J; Guhan B
J Reprod Med; 2006 Oct; 51(10):835-40. PubMed ID: 17086813
[TBL] [Abstract][Full Text] [Related]
26. Demographic analysis of post-abortive and interval-administered hormonal contraceptive methods.
Ertopçu K; Inal MM; Ozelmas I
Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):1-5. PubMed ID: 16036290
[TBL] [Abstract][Full Text] [Related]
27. [Study on follow-up procedure for postmolar patients].
Endo N; Kobayashi O; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):531-8. PubMed ID: 6715935
[TBL] [Abstract][Full Text] [Related]
28. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
Elmer DB; Granai CO; Ball HG; Curry SL
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Myer L; Denny L; Wright TC; Kuhn L
Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
[TBL] [Abstract][Full Text] [Related]
30. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
[TBL] [Abstract][Full Text] [Related]
31. Clinical and laboratory correlates of molar pregnancy and trophoblastic disease.
Morrow CP; Kletzky OA; Disaia PJ; Townsend DE; Mishell DR; Nakamura RM
Am J Obstet Gynecol; 1977 Jun; 128(4):424-30. PubMed ID: 194480
[TBL] [Abstract][Full Text] [Related]
32. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
Ngan HY; Wong LC
Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
[TBL] [Abstract][Full Text] [Related]
33. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
34. Predictors of low risk of persistent trophoblastic disease in molar pregnancies.
Niemann I; Petersen LK; Hansen ES; Sunde L
Obstet Gynecol; 2006 May; 107(5):1006-11. PubMed ID: 16648403
[TBL] [Abstract][Full Text] [Related]
35. Gestational trophoblastic neoplasia following molar ectopic pregnancy: a case report.
Soares PD; Costa OL; Costa LA; Maestá I
J Reprod Med; 2008 Aug; 53(8):579-82. PubMed ID: 18773621
[TBL] [Abstract][Full Text] [Related]
36. Postmolar contraception.
Pandiyan N; Jequier AM
Obstet Gynecol Surv; 1988 May; 43(5):258-62. PubMed ID: 3287245
[TBL] [Abstract][Full Text] [Related]
37. Prognostic characteristics of serum human chorionic gonadotropin titer regression following molar pregnancy.
Schlaerth JB; Morrow CP; Kletzky OA; Nalick RH; D'Ablaing GA
Obstet Gynecol; 1981 Oct; 58(4):478-82. PubMed ID: 7279342
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
39. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
Franke HR; Risse EK; Kenemans P; Houx PC; Stolk JG; Vooijs GP
Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
[TBL] [Abstract][Full Text] [Related]
40. Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy.
Lertkhachonsuk R; Limpongsanurak S
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S352-9. PubMed ID: 11529357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
